Home » Topics » Regulatory

Regulatory
RSS

FDA approves Vemlidy to treat chronic HBV infection

Nov. 11, 2016

FDA approves Opdivo for head and neck cancer

Nov. 11, 2016

FDA approves Enbrel to treat children with moderate to severe plaque psoriasis

Nov. 7, 2016

Silvergate announces U.S. availability of Qbrelis

Oct. 27, 2016

FDA issues new approvals in NSCLC for Keytruda

Oct. 25, 2016

FDA approves Zinplava to reduce recurrence of C. difficile infection

Oct. 24, 2016

FDA grants accelerated approval for Lartruvo in soft tissue sarcoma

Oct. 20, 2016

FDA approves Tecentriq for metastatic NSCLC

Oct. 19, 2016

FDA approves infant-specific dose of Pertzye

Oct. 13, 2016

FDA approves Carnexiv as intravenous short-term replacement therapy for seizures

Oct. 10, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...